Technical Analysis for CNCE - Concert Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 9.86 5.45% 0.51
CNCE closed up 5.45 percent on Friday, August 7, 2020, on approximately normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up
Historical CNCE trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
200 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Earnings Movers Other 0.00%
Multiple of Ten Bearish Other 0.00%
20 DMA Resistance Bearish 5.45%
200 DMA Support Bullish 5.45%
Earnings Movers Other 5.45%
Outside Day Range Expansion 5.45%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Concert Pharmaceuticals, Inc., a biotechnology company, develops drug candidates. Its drug candidates address various therapeutic areas, including hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, schizophrenia, multiple tumors, and hyperparathyroidism, as well as provide agents for diabetic nephropathy and other forms of chronic kidney diseases. The company also develops CTP-354, a GABA(A) receptor subtype-selective modulator for the treatment of spasticity and chronic pain. Concert Pharmaceuticals, Inc. has strategic alliances with GlaxoSmithKline plc and Celgene Corporation. The company was founded in 2006 and is based in Lexington, Massachusetts.
Medicine Biotechnology Medical Specialties Life Sciences Pain Schizophrenia Tumors Chronic Kidney Disease HIV Chronic Pain Kidney Diseases Diabetic Nephropathy Bristol Myers Squibb Celgene Summit

Is CNCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.09
52 Week Low 5.36
Average Volume 135,661
200-Day Moving Average 9.19
50-Day Moving Average 9.89
20-Day Moving Average 9.77
10-Day Moving Average 9.31
Average True Range 0.73
ADX 16.23
+DI 18.77
-DI 19.50
Chandelier Exit (Long, 3 ATRs ) 8.57
Chandelier Exit (Short, 3 ATRs ) 10.65
Upper Bollinger Band 10.81
Lower Bollinger Band 8.73
Percent B (%b) 0.54
BandWidth 21.35
MACD Line -0.15
MACD Signal Line -0.15
MACD Histogram -0.0061
Fundamentals Value
Market Cap 223.69 Million
Num Shares 22.7 Million
EPS -2.22
Price-to-Earnings (P/E) Ratio -4.44
Price-to-Sales 4493.13
Price-to-Book 5.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.75
Resistance 3 (R3) 11.68 10.98 11.44
Resistance 2 (R2) 10.98 10.50 11.02 11.33
Resistance 1 (R1) 10.42 10.20 10.70 10.49 11.22
Pivot Point 9.72 9.72 9.86 9.76 9.72
Support 1 (S1) 9.16 9.24 9.44 9.23 8.50
Support 2 (S2) 8.46 8.94 8.50 8.39
Support 3 (S3) 7.90 8.46 8.29
Support 4 (S4) 7.97